Actively hiring
Health Care
Genomics & Genetic Testing
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$2.8M
1 round on record
Latest round
$2.8M
Venture round · May 2025 · 16 mo ago
Team
201-500
employees, estimated range
Backers
1
OCA Ventures
The money's age
Due for its next round
16 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jan 8
Partnership OrisDX and Teledentistry.com Announce Strategic Partnership to Expand Access to Early Oral Cancer Detection · tennessean.com
May 23, 2025
Raised a round Venture round $2.8M · SEC Form D
2022
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | May 2025 | $2.8M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | OrisDx Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Harald SteltzerExecutive Officer, DirectorSEC Form D
Patrick ConniffExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers

Spartan is bringing complete sample-to-result DNA testing systems to medicine. Spartan.

Phenomix Sciences uses AI for precision obesity medicine integrating genetic, clinical, and biomarker data. Deliver the right intervention…

TECHNOLOGY M20 Seq Single-Cell Transcriptome M20 Spatial Spatial Transcriptome PRODUCTS Single-Cell Transcriptome for FFPE Samples…

Volta Labs is a genomics applications company that has developed a cutting-edge sample prep system to improve performance, scalability, and…

The next generation of genome-wide on- and off-target analysis in your own hands. Our INDUCE-seq platform provides precise off-target…

PathoQuest provides biosafety assays based on next-generation sequencing (NGS) for biologics quality testing. GMP biotesting for…
News
OrisDX and Teledentistry.com Announce Strategic Partnership to Expand Access to Early Oral Cancer Detection
Read more
Report
Orisdx Raises $4M Seed To Launch First-Of-Its-Kind Saliva-Based Multiomic Platform, Targeting Oral Cancer
Read more
Report
OrisDX Raises $4M Seed to Launch First-of-Its-Kind Saliva-Based Multiomic Platform, Targeting Oral Cancer
Read more
Report
Faced with late-stage diagnoses, UChicago physicians help create saliva test to detect cancer earlier
Developing a non-invasive test, OrisDX aims to offer a 'game changer' for detecting oral cancer
Read more
Report
People

Harald Steltzer
Executive Officer, Director

Patrick Conniff
Executive Officer

Evgeny Izmchenko
Director

Nishant Agrawal
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Chicago
United States
HQ
200-500 est. staff
Financials
Total raised
$2.8M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2025 | $2.8M | Details |

OCA Ventures